Previous studies have shown that the transcription factor MYBL plays a role in the growth and spread of bladder cancer, while reducing MYBL2 levels effectively inhibits the proliferation and spread of bladder cancer cells, resulting in a halt in the G2 phase (53). This evidence concerns the gene MYBL2 and urinary bladder cancer.